← back to database

CTI Life Sciences Fund

HQ · Quebec
WebsiteLinkedInUpdate entry

CTI Life Sciences Fund is a Canadian biotechnology investor and company builder that turns nascent therapeutic ideas and assets into investable, scalable companies, using a modality-agnostic approach across preclinical and clinical development.

Stage focus
Pre-Seed / InceptionSeedSeries A
Specialization
Life Sciences
Generalist / Specialist

Specialist

Investing team
  • Dana Matzen, PartnerDana MatzenPartner
  • Ken Pastor, Managing PartnerKen PastorManaging Partner
  • Laurence Rulleau, Managing PartnerLaurence RulleauManaging Partner
  • Shermaine TileyManaging Partner
  • Xin Hang, Senior PrincipalXin HangSenior Principal
  • Youssef Bennani, Managing PartnerYoussef BennaniManaging Partner
How to reach them

nnorthcott@ctisciences.com

Notable investments

Zymeworks, Vaxcyte, Glycomine, Kainova Therapeutics, Profound Medical, Ability Pharma

Sources
ctisciences.com ↗ctisciences.com/portfolio ↗ctisciences.com/team/ken-pastor ↗

Spotted an error on this profile?

Similar firms

DimensionPre-Seed / Inception · Seed · $3m–$30mview profile →Good Growth CapitalPre-Seed / Inception · Seed · $250k–$3mview profile →Amplify PartnersPre-Seed / Inception · Seed · $500k–$10mview profile →